Guangdong Jincheng Jinsu Pharmaceutical Co Ltd.

Main study objectives To study the pharmacokinetics of a single oral dose of the test preparation cefdinir dry suspension (specification: 250mg/5ml, provided by Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd.) and the reference preparation cefdinir dry suspension (specification: 250mg/5ml, licensee: Aurobindo Pharma Limited) in healthy adult subjects under fasting and fed conditions, and to evaluate the bioequivalence of the two preparations when taken orally under fasting and fed conditions. Secondary study objectives To evaluate the safety of a single oral dose of the test preparation cefdinir dry suspension and the reference preparation cefdinir dry suspension in healthy Chinese subjects under fasting and fed conditions.

Main purpose: To conduct a formal bioequivalence test using Penicillin V Potassium Tablets produced by Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd. as the test preparation and Penicillin V Potassium Tablets certified by Sandoz GmbH as the reference preparation.

Main research purpose Study the single oral administration of the test preparation Amlodipine besylate orally disintegrating tablets (specification: 10 mg, produced by Shenzhen Xinlitai Pharmaceutical Co., Ltd., licensed by Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd.) and the reference in the fasting and postprandial states. Preliminary pharmacokinetics of the preparation amlodipine besylate orally disintegrating tablets (trade name: ノルバスク®, specification: 10 mg, manufactured by ヴィアトリス薬 Co., Ltd., licensed by ヴィアトリス疬 Co., Ltd.) in healthy adult subjects The bioequivalence of the two formulations was evaluated for fasting and postprandial oral administration. Secondary research purpose To evaluate the safety of test preparation (T) amlodipine besylate orally disintegrating tablets and reference preparation (R) amlodipine besylate orally disintegrating tablets (ノルバスク®) administered to healthy subjects on an empty stomach and after a meal. sex.